In the last 90 days, Larimar Therapeutics, Inc. insiders filed 8 open-market purchases and 0 sales; 145 institutions reported holding it in 13F filings for Q3 2026, worth $332.8M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Larimar Therapeutics, Inc. filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
3.02Item 3.02: Unregistered sale of equity securities5.03Item 5.03: Amendment to the articles of incorporation or bylaws; change in fiscal year9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
3.02Item 3.02: Unregistered sale of equity securities5.03Item 5.03: Amendment to the articles of incorporation or bylaws; change in fiscal year9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits
2.02Item 2.02: Results of operations and financial condition (earnings release)8.01Item 8.01: Other events9.01Item 9.01: Financial statements and exhibits